JP2016516985A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516985A5 JP2016516985A5 JP2015562256A JP2015562256A JP2016516985A5 JP 2016516985 A5 JP2016516985 A5 JP 2016516985A5 JP 2015562256 A JP2015562256 A JP 2015562256A JP 2015562256 A JP2015562256 A JP 2015562256A JP 2016516985 A5 JP2016516985 A5 JP 2016516985A5
- Authority
- JP
- Japan
- Prior art keywords
- abnormalities
- pharmaceutical composition
- stem cells
- human subject
- mesenchymal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382091.0 | 2013-03-15 | ||
| EP13382091 | 2013-03-15 | ||
| PCT/EP2014/055282 WO2014140362A2 (en) | 2013-03-15 | 2014-03-17 | Lymphocyte biomarkers for determining the clinical response to cell therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019140842A Division JP6883070B2 (ja) | 2013-03-15 | 2019-07-31 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516985A JP2016516985A (ja) | 2016-06-09 |
| JP2016516985A5 true JP2016516985A5 (enExample) | 2017-04-27 |
| JP6567430B2 JP6567430B2 (ja) | 2019-08-28 |
Family
ID=48044710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015562256A Expired - Fee Related JP6567430B2 (ja) | 2013-03-15 | 2014-03-17 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
| JP2019140842A Expired - Fee Related JP6883070B2 (ja) | 2013-03-15 | 2019-07-31 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019140842A Expired - Fee Related JP6883070B2 (ja) | 2013-03-15 | 2019-07-31 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10660920B2 (enExample) |
| EP (2) | EP2972368B1 (enExample) |
| JP (2) | JP6567430B2 (enExample) |
| AU (2) | AU2014230014B2 (enExample) |
| CA (2) | CA3188652A1 (enExample) |
| DK (1) | DK2972368T3 (enExample) |
| ES (1) | ES2748825T3 (enExample) |
| HU (1) | HUE046531T2 (enExample) |
| IL (1) | IL241586B (enExample) |
| PL (1) | PL2972368T3 (enExample) |
| PT (1) | PT2972368T (enExample) |
| SG (1) | SG11201507521UA (enExample) |
| WO (1) | WO2014140362A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| SG10202001007TA (en) | 2005-09-23 | 2020-03-30 | Tigenix Sau | Cell populations having immunoregulatory activity, method for isolation and uses |
| ES2748825T3 (es) | 2013-03-15 | 2020-03-18 | Tigenix S A U | Biomarcadores de linfocitos para determinar la respuesta clínica a la terapia celular |
| JP6811724B2 (ja) * | 2015-04-24 | 2021-01-13 | ティジェニクス エス．エー．ユー． | 細胞療法に対する臨床応答を決定するためのバイオマーカー |
| GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| TW201831681A (zh) * | 2016-11-11 | 2018-09-01 | 美商生命科學公司 | 使用人類間葉幹細胞以實現細胞性及體液性免疫的方法 |
| JP7628499B2 (ja) * | 2019-02-27 | 2025-02-10 | 武田薬品工業株式会社 | 同種異系療法のための改良された幹細胞集団 |
| WO2021207192A1 (en) * | 2020-04-08 | 2021-10-14 | Figene, Llc | Methods and compositions for allergy and asthma treatment using fibroblasts |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1226828B1 (en) * | 1999-10-20 | 2009-12-09 | Chugai Seiyaku Kabushiki Kaisha | Use of g-csf for inhibiting gvhd |
| CA2564679C (en) * | 2004-03-22 | 2015-06-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| EP1871419A4 (en) * | 2005-04-22 | 2009-01-14 | Univ Maryland | METHOD FOR THE TREATMENT OF TRANSPLANT-AGAINST RECIPIENT DISEASE |
| WO2012154344A1 (en) * | 2011-04-06 | 2012-11-15 | Sanbio, Inc. | Methods and compositions for modulating peripheral immune function |
| ES2748825T3 (es) | 2013-03-15 | 2020-03-18 | Tigenix S A U | Biomarcadores de linfocitos para determinar la respuesta clínica a la terapia celular |
-
2014
- 2014-03-17 ES ES14712628T patent/ES2748825T3/es active Active
- 2014-03-17 JP JP2015562256A patent/JP6567430B2/ja not_active Expired - Fee Related
- 2014-03-17 DK DK14712628.8T patent/DK2972368T3/da active
- 2014-03-17 AU AU2014230014A patent/AU2014230014B2/en active Active
- 2014-03-17 SG SG11201507521UA patent/SG11201507521UA/en unknown
- 2014-03-17 CA CA3188652A patent/CA3188652A1/en active Pending
- 2014-03-17 PT PT147126288T patent/PT2972368T/pt unknown
- 2014-03-17 EP EP14712628.8A patent/EP2972368B1/en active Active
- 2014-03-17 EP EP19187915.4A patent/EP3581932A1/en not_active Withdrawn
- 2014-03-17 PL PL14712628T patent/PL2972368T3/pl unknown
- 2014-03-17 CA CA2906299A patent/CA2906299C/en active Active
- 2014-03-17 WO PCT/EP2014/055282 patent/WO2014140362A2/en not_active Ceased
- 2014-03-17 HU HUE14712628A patent/HUE046531T2/hu unknown
- 2014-03-17 US US14/776,233 patent/US10660920B2/en active Active
-
2015
- 2015-09-16 IL IL241586A patent/IL241586B/en active IP Right Grant
-
2019
- 2019-07-31 JP JP2019140842A patent/JP6883070B2/ja not_active Expired - Fee Related
-
2020
- 2020-02-05 AU AU2020200807A patent/AU2020200807B2/en active Active
- 2020-04-21 US US16/854,294 patent/US11478511B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015131795A5 (enExample) | ||
| GB2569921A (en) | Bisymmetric comparison of sub-epidermal moisture values | |
| WO2019006005A3 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | |
| Niknejad et al. | Anticancer effects of human amniotic membrane and its epithelial cells | |
| EA201691516A1 (ru) | Дигидропирролопиридиновые ингибиторы ror-гамма | |
| JP2016500698A5 (enExample) | ||
| WO2017062456A3 (en) | Biomarkers related to interleukin-33 (il-33)-mediated diseases and uses thereof | |
| IN2015DN00376A (enExample) | ||
| EP4353319A3 (en) | Methods of adoptive cell therapy | |
| WO2015148389A3 (en) | Diagnosis of multiple sclerosis in human and animal subjects | |
| EA201790563A1 (ru) | Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой | |
| EP4252742A3 (en) | Fluticasone furoate in the treatment of copd | |
| BR112017001971A2 (pt) | ?métodos e composições para diagnosticar e tratar distúrbios inflamatórios intestinais? | |
| JP2012518646A5 (enExample) | ||
| MX2017014857A (es) | Metodos para diagnosticar y evaluar tratamiento para sindrome de cushing. | |
| WO2015120436A3 (en) | Stat3 phosphorylation during graft-versus-host disease | |
| EP4356967A3 (en) | Compounds for use as imaging agents | |
| ME03295B (me) | Inhibitor transfer proteina holesteril estra (cetp) i farmaceutske kompozicije koje sadrže pomenuti inhibitor za upotrebu u tretmanu ili prevenciji kardiovaskularnih bolesтi | |
| WO2019055776A3 (en) | Compositions and methods for treatment of diseases involving cxcl1 function | |
| WO2016081733A3 (en) | Compositions and methods for modulating at2r activity | |
| BR112012030051A2 (pt) | índice de saúde oral | |
| Chastek et al. | C31 CLINICAL ASTHMA I: The Few Who Use The Most: Costs Of Severe And Persistent Asthma In A Us Managed Care Plan | |
| EP4328245A3 (en) | Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations | |
| Yanishen et al. | Dentures quality at the stages of its clinical durability | |
| Yelnikova | Problems and perspectives of physical rehabilitation of men with metabolic syndrome at the second period of of mature age |